CIK 0001729427 · Non-accelerated filer<br>Smaller reporting company
CNS Pharmaceuticals, Inc.
Sign in to watch- Ticker
- CNSP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 822318545
- Phone
- 1-800-946-9185
- Business address
- 2100 WEST LOOP SOUTH, SUITE 900, HOUSTON, TX, 77027
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-01 | Climaco John M Chief Executive Officer | Purchase | +166,666 | $0.30 | $50K | 215,676 |
| 2024-02-01 | Climaco John M Chief Executive Officer | Grant or award · Series A Warrant to purchase common stock | +166,666 | 226,867 | ||
| 2024-02-01 | Climaco John M Chief Executive Officer | Grant or award · Series B Warrant to purchase common stock | +166,666 | 393,533 | ||
| 2023-09-21 | Gumulka Jerzy Director | Grant or award · Option to purchase common stock | +39,475 | 45,428 | ||
| 2023-09-21 | Evans Carl Anthony Director | Grant or award · Option to purchase common stock | +39,475 | 45,428 | ||
| 2023-09-21 | Keyes Jeffry R. Director | Grant or award · Option to purchase common stock | +39,475 | 45,428 | ||
| 2023-09-21 | Cockroft Bettina M. Director | Grant or award · Option to purchase common stock | +9,475 | 18,074 | ||
| 2023-09-21 | Charles Faith L. Director | Grant or award · Option to purchase common stock | +26,315 | 29,815 | ||
| 2023-09-21 | Andraczke Andrzej Director | Grant or award · Option to purchase common stock | +39,475 | 45,428 | ||
| 2023-09-21 | Keyes Jeffry R. Director | Grant or award · Option to purchase common stock | +68,961 | 74,914 | ||
| 2023-09-21 | Gumulka Jerzy Director | Grant or award · Option to purchase common stock | +68,961 | 74,914 | ||
| 2023-09-21 | Evans Carl Anthony Director | Grant or award · Option to purchase common stock | +68,961 | 74,914 | ||
| 2023-09-21 | Cockroft Bettina M. Director | Grant or award · Option to purchase common stock | +16,551 | 74,914 | ||
| 2023-09-21 | Charles Faith L. Director | Grant or award · Option to purchase common stock | +45,974 | 74,914 | ||
| 2023-09-21 | Andraczke Andrzej Director | Grant or award · Option to purchase common stock | +68,961 | 74,914 | ||
| 2023-09-14 | Cockroft Bettina M. Director | Grant or award · Option to purchase common stock | +6,500 | 8,599 | ||
| 2023-08-22 | Downs Christopher Chief Financial Officer | Purchase | +27,000 | $1.27 | $34K | 36,772 |
| 2023-08-16 | Climaco John M Chief Executive Officer | Purchase | +2,750 | $1.80 | $5K | 49,010 |
| 2023-05-05 | Cockroft Bettina M. Director | Grant or award · Option to purchase common stock | +2,099 | 2,099 | ||
| 2023-05-05 | Cockroft Bettina M. Director | Grant or award · Option to purchase common stock | +8,300 | 8,300 |
Page 3 of 6 · 110 trades